<p><b><i>A</i></b>, CASP2, C-CASP2 and <b><i>B</i></b>, CASP3, C-CASP3 in DRGN and satellite cells grown in the presence of serum (D+S) or after serum withdrawal (D−S). <b><i>C</i></b>, Double immunostaining for C-CASP2 in βIII-tubulin<sup>+</sup> DRGN (arrow) and C-CASP2<sup>+</sup> in βIII-tubulin<sup>−</sup> satellite cells (arrowheads). Scale bars in <i>A</i>–<i>C</i> = 50 µm.</p
<p>SAOS-2 cells grown for 5 days in the hydrofocusing bioreactor and treated with 10 µg/mL of CDDP d...
<p>DR5 was predominantly expressed on neutrophil cell surface. A: The fraction of neutrophils within...
<p>(A, B) NL20 and A549 cells treated with (lanes 2,4) and without (lanes 1,3) 1 µM STS for 3 hours ...
<p><b><i>A</i></b>, <b><i>B</i></b>, Constitutive low levels of C-CASP2 and C-CASP3 in control DRGN ...
<p>The patterns of C-CASP2 immunocytochemistry included cytosolic (arrow) but not nuclear expression...
<p><b><i>A</i></b>, Western blot and <b><i>B</i></b>, subsequent densitometry to show CASP2 and CASP...
<p>C-CASP3 localisation in DRGN grown in both the presence of serum (D+S) and after serum withdrawal...
<p>(A) Immunohistochemistry to show the absence of C-CASP2 (red) reactivity in βIII-tubulin<sup>+</s...
<p>(A, B) C-CASP2 is highly up regulated in ONC+vehicle treated in the GCL and INL cells. (C, D) C-C...
<p>Casp-2S was either over-expressed in A2780 and 2008 cells (A), or knocked down in CDDP cells and ...
<p>A, Casp-2S was purified from HeLa cells stably transfected with the FLAG-tagged casp-2S using an ...
<p>Casp-2S was over-expressed in A2780 cells (A), or knocked down in CDDP cells (B) for 48 h. Cells ...
<p>(A) H4-APP cells were transiently transfected with shRNA to caspase-3 or shRNA to caspase-7 and t...
<p>(A) Primary cultures of <i>Casp2<sup>+/+</sup></i> osteoclasts treated with 500 μM H<sub>2</sub>O...
<p>Casp-2S was either over-expressed in A2780 cells and 2008 cells (A), or knocked down in CDDP cell...
<p>SAOS-2 cells grown for 5 days in the hydrofocusing bioreactor and treated with 10 µg/mL of CDDP d...
<p>DR5 was predominantly expressed on neutrophil cell surface. A: The fraction of neutrophils within...
<p>(A, B) NL20 and A549 cells treated with (lanes 2,4) and without (lanes 1,3) 1 µM STS for 3 hours ...
<p><b><i>A</i></b>, <b><i>B</i></b>, Constitutive low levels of C-CASP2 and C-CASP3 in control DRGN ...
<p>The patterns of C-CASP2 immunocytochemistry included cytosolic (arrow) but not nuclear expression...
<p><b><i>A</i></b>, Western blot and <b><i>B</i></b>, subsequent densitometry to show CASP2 and CASP...
<p>C-CASP3 localisation in DRGN grown in both the presence of serum (D+S) and after serum withdrawal...
<p>(A) Immunohistochemistry to show the absence of C-CASP2 (red) reactivity in βIII-tubulin<sup>+</s...
<p>(A, B) C-CASP2 is highly up regulated in ONC+vehicle treated in the GCL and INL cells. (C, D) C-C...
<p>Casp-2S was either over-expressed in A2780 and 2008 cells (A), or knocked down in CDDP cells and ...
<p>A, Casp-2S was purified from HeLa cells stably transfected with the FLAG-tagged casp-2S using an ...
<p>Casp-2S was over-expressed in A2780 cells (A), or knocked down in CDDP cells (B) for 48 h. Cells ...
<p>(A) H4-APP cells were transiently transfected with shRNA to caspase-3 or shRNA to caspase-7 and t...
<p>(A) Primary cultures of <i>Casp2<sup>+/+</sup></i> osteoclasts treated with 500 μM H<sub>2</sub>O...
<p>Casp-2S was either over-expressed in A2780 cells and 2008 cells (A), or knocked down in CDDP cell...
<p>SAOS-2 cells grown for 5 days in the hydrofocusing bioreactor and treated with 10 µg/mL of CDDP d...
<p>DR5 was predominantly expressed on neutrophil cell surface. A: The fraction of neutrophils within...
<p>(A, B) NL20 and A549 cells treated with (lanes 2,4) and without (lanes 1,3) 1 µM STS for 3 hours ...